- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/64 - Proteinases derived from animal tissue, e.g. rennin
Patent holdings for IPC class C12N 9/64
Total number of patents in this class: 2220
10-year publication summary
149
|
183
|
202
|
210
|
209
|
214
|
213
|
172
|
144
|
56
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immatics Biotechnologies GmbH | 1144 |
91 |
Takeda Pharmaceutical Company Limited | 2961 |
52 |
Bioverativ Therapeutics Inc. | 220 |
48 |
Regeneron Pharmaceuticals, Inc. | 3650 |
46 |
Modernatx, Inc. | 1181 |
39 |
Chr. Hansen A/S | 979 |
35 |
Alexion Pharmaceuticals, Inc. | 606 |
30 |
The Children's Hospital of Philadelphia | 716 |
23 |
The Trustees of the University of Pennsylvania | 4122 |
22 |
Laboratoire Francais du Fractionnement et des Biotechnologies | 306 |
20 |
Novo Nordisk Health Care AG | 342 |
20 |
Vertex Pharmaceuticals Incorporated | 1581 |
18 |
Translate bio, Inc. | 394 |
17 |
F. Hoffmann-La Roche AG | 7958 |
16 |
Opko Biologics Ltd. | 75 |
16 |
Novozymes A/S | 3314 |
15 |
Octapharma AG | 201 |
14 |
Research Development Foundation | 234 |
14 |
The Regents of the University of California | 18943 |
13 |
Genentech, Inc. | 3742 |
13 |
Other owners | 1658 |